Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog, Sue Healey, Douglas F Easton, Olga Sinilnikova, Javier Benítez, María J García, Susan Neuhausen, Mitchell H Gail, Patricia Hartge, Susan Peock, Debra FrostD Gareth Evans, Rosalind Eeles, Andrew K Godwin, Mary B Daly, Ava Kwong, Edmond S K Ma, Conxi Lázaro, Ignacio Blanco, Marco Montagna, Emma D'Andrea, Maria Ornella Nicoletto, Sharon E Johnatty, Susanne Krüger Kjær, Allan Jensen, Estrid Høgdall, Ellen L Goode, Brooke L Fridley, Jennifer T Loud, Mark H Greene, Phuong L Mai, Angela Chetrit, Flora Lubin, Galit Hirsh-Yechezkel, Gord Glendon, Irene L Andrulis, Amanda E Toland, Leigha Senter, Martin E Gore, Charlie Gourley, Caroline O Michie, EMBRACE

567 Citationer (Scopus)

Abstract

Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains unclear.
OriginalsprogEngelsk
TidsskriftJ A M A: The Journal of the American Medical Association
Vol/bind307
Udgave nummer4
Sider (fra-til)382-90
Antal sider9
ISSN0098-7484
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater